UK MHRA issues guidance on vigilance requirements of intraocular lenses
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has issued draft recommendations for manufacturers of CE-marked intraocular lenses and coronary stents on the notification of adverse events related to their products under the European medical device vigilance system1,2.